Mountain View, California
United States
162
2020-10-06
138
2020-10-06
These are the the leading inventors for applications assigned to ChemoCentryx, Inc.:
ChemoCentryx, Inc. based in Mountain View, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-TNF-alpha blocking antibodies
#2 | 2020-04-23 ✅ Patent 10,759,789 granted on 2020-09-012-oxindole compounds
#3 | 2020-02-06 ✅ Patent 10,988,464 granted on 2021-04-27Modulators of chemokine receptors
#4 | 2019-11-21 ✅ Patent 10,583,131 granted on 2020-03-10Methods of treating pancreatic cancer
#5 | 2019-09-19 ✅ Patent 10,568,874 granted on 2020-02-25Indane-amines as PD-L1 antagonists
#6 | 2019-09-12 ✅ Patent 10,532,982 granted on 2020-01-14Processes and intermediates in the preparation of C5aR antagonists
#7 | 2019-09-05 ✅ Patent 10,487,098 granted on 2019-11-26Soluble C5aR antagonists
#8 | 2019-06-27 ✅ Patent 10,759,807 granted on 2020-09-01Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors
#9 | 2019-06-27 ✅ Patent 10,828,285 granted on 2020-11-10Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors
#10 | 2019-06-06 ✅ Patent 10,899,765 granted on 2021-01-26Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation
#11 | 2019-06-06 ✅ Patent 10,786,494 granted on 2020-09-29CCR6 compounds
#12 | 2019-06-06 ✅ Patent 10,532,044 granted on 2020-01-14Heteroaryl sulfonamides and CCR2/CCR9
#13 | 2019-06-06 ✅ Patent 10,398,685 granted on 2019-09-03Methods of treating pancreatic cancer
#14 | 2019-05-09 ✅ Patent 10,919,852 granted on 2021-02-16Immunomodulator compounds
#15 | 2019-05-09 ✅ Patent 10,758,540 granted on 2020-09-01Treatment of focal segmental glomerulosclerosis with CCR2 antagonists
#16 | 2019-02-28 ✅ Patent 10,660,897 granted on 2020-05-26C5aR antagonists
#17 | 2019-02-28 ✅ Patent 10,596,163 granted on 2020-03-24Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides
#18 | 2019-02-14 ✅ Patent 10,392,405 granted on 2019-08-27Macrocyclic immunomodulators
#19 | 2019-01-17 ✅ Patent 10,421,748 granted on 2019-09-242-oxindole compounds
#20 | 2019-01-10 ✅ Patent 10,329,314 granted on 2019-06-25Soluble C5aR antagonists
#21 | 2018-12-27 ✅ Patent 10,562,896 granted on 2020-02-186-5 fused rings as C5a inhibitors
#22 | 2018-12-06 ✅ Patent 10,683,294 granted on 2020-06-165-5 fused rings as C5a inhibitors
#23 | 2018-06-28 ✅ Patent 10,035,768 granted on 2018-07-31C5aR antagonists
#24 | 2018-06-21 ✅ Patent 10,370,363 granted on 2019-08-06Inhibitors of CXCR2
#25 | 2018-06-14 ✅ Patent 10,407,417 granted on 2019-09-10Substituted anilines as CCR(4) antagonists
#26 | 2018-05-24 ✅ Patent 10,336,736 granted on 2019-07-02Modulators of chemokine receptors
#27 | 2018-05-24 ✅ Patent 10,973,809 granted on 2021-04-13Method of treating focal segmental glomerulosclerosis
#28 | 2018-05-10 ✅ Patent 10,647,696 granted on 2020-05-12Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists
#29 | 2018-04-05 ✅ Patent 10,117,865 granted on 2018-11-06CCR6 compounds
#30 | 2018-03-29 ✅ Patent 10,287,292 granted on 2019-05-14CXCR7 antagonists
#31 | 2018-03-29 ✅ Patent 10,464,934 granted on 2019-11-05Substituted tetrahydropyrans as CCR2 modulators
#32 | 2018-03-15 ✅ Patent 10,266,492 granted on 2019-04-23Processes and intermediates in the preparation of C5aR antagonists
#33 | 2018-03-15 ✅ Patent 10,342,781 granted on 2019-07-09Diazole amides
#34 | 2018-01-11 ✅ Patent 10,639,284 granted on 2020-05-05Immunomodulator compounds
#35 | 2017-12-28 ✅ Patent 10,364,240 granted on 2019-07-30Aryl sulfonamides
#36 | 2017-12-28 ✅ Patent 10,195,188 granted on 2019-02-05Method of treating pancreatic cancer
#37 | 2017-12-14 ✅ Patent 10,251,888 granted on 2019-04-09Method of treating pancreatic cancer
#38 | 2017-12-07 ✅ Patent 10,682,344 granted on 2020-06-16Method of treating liver fibrosis
#39 | 2017-11-23 ✅ Patent 10,208,050 granted on 2019-02-19Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation
#40 | 2017-10-12 ✅ Patent 10,568,870 granted on 2020-02-25Reducing tumor burden by administering CCR1 antagonists in combination with PD-1 inhibitors or PD-L1 inhibitors
#41 | 2017-05-25 ✅ Patent 9,834,545 granted on 2017-12-05Modulators of chemokine receptors
#42 | 2017-05-25 ✅ Patent 9,809,581 granted on 2017-11-07Inhibitors of CXCR2
#43 | 2017-04-06 ✅ Patent 10,206,912 granted on 2019-02-19Heteroaryl sulfonamides and CCR2/CCR9
#44 | 2017-01-26 ✅ Patent 9,745,312 granted on 2017-08-29Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation
#45 | 2017-01-26 ✅ Patent 9,809,548 granted on 2017-11-07Polymorphic forms of the sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzene sulfonamide
#46 | 2016-11-24 ✅ Patent 9,783,540 granted on 2017-10-10Substituted tetrahydropyrans as CCR2 modulators
#47 | 2016-11-03 ✅ Patent 9,758,512 granted on 2017-09-12Substituted anilines as CCR(4) antagonists
#48 | 2016-10-20 ✅ Patent 10,744,118 granted on 2020-08-18Diazole lactams
#49 | 2016-10-13 ✅ Patent 9,795,599 granted on 2017-10-24CCR6 compounds
#50 | 2016-08-11 ✅ Patent 9,573,897 granted on 2017-02-21C5AR antagonists
#51 | 2016-07-07 ✅ Patent 9,750,722 granted on 2017-09-05Diazole amides
#52 | 2016-06-30 ✅ Patent 9,790,204 granted on 2017-10-17Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists
#53 | 2016-05-26 ✅ Patent 9,783,544 granted on 2017-10-10CXCR7 antagonists
#54 | 2016-04-07 ✅ Patent 10,532,051 granted on 2020-01-14Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C-C chemokine receptor 9 (CCR9) and anti-α4β7 integrin blocking antibodies
#55 | 2016-03-31 ✅ Patent 9,745,268 granted on 2017-08-29Processes and intermediates in the preparation of C5aR antagonists
#56 | 2016-02-11 ✅ Patent 9,493,417 granted on 2016-11-15Polymorphic forms of the sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide
#57 | 2016-02-11 ✅ Patent 9,464,054 granted on 2016-10-11Polymorphic forms of the sodium salt of 4-tert-butyl-N-[4-CHLOR0-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide
#58 | 2015-06-25 ✅ Patent 9,340,509 granted on 2016-05-17CCR6 compounds
#59 | 2015-05-21 ✅ Patent 9,567,323 granted on 2017-02-14Substituted anilines as CCR(4) antagonists
#60 | 2015-03-19 ✅ Patent 9,890,148 granted on 2018-02-13Aryl sulfonamides
#61 | 2015-03-12 ✅ Patent 10,137,120 granted on 2018-11-27Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides
#62 | 2015-01-15 ✅ Patent 9,409,909 granted on 2016-08-09N-(2-(hetaryl)aryl)arylsulfonamides and N-(2-(hetaryl)hetaryl)arylsulfonamides
#63 | 2014-06-26 ✅ Patent 9,169,248 granted on 2015-10-27Diazole amides
#64 | 2014-06-19 ✅ Patent 9,150,513 granted on 2015-10-06Polymorphic forms of the sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzene sulfonamide
#65 | 2014-06-19 ✅ Patent 9,328,116 granted on 2016-05-03Diazole lactams
#66 | 2014-06-05 ✅ Patent 9,139,526 granted on 2015-09-22Polymorphic forms of the sodium salt of 4--butyl--[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide
#67 | 2014-06-05 ✅ Patent 9,169,261 granted on 2015-10-27CXCR7 antagonists
#68 | 2014-05-01 ✅ Patent 9,150,550 granted on 2015-10-06Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists
#69 | 2014-04-10 ✅ Patent 9,394,307 granted on 2016-07-19Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation
#70 | 2014-02-27 ✅ Patent 9,181,241 granted on 2015-11-10Antagonists of chemokine receptors
#71 | 2013-12-19 ✅ Patent 9,296,740 granted on 2016-03-29Azaindazole compounds and methods of use
#72 | 2013-11-28 ✅ Patent 8,906,938 granted on 2014-12-09C5aR antagonists
#73 | 2013-10-10ARYL SULFONAMIDES
#74 | 2013-09-12 ✅ Patent 8,716,494 granted on 2014-05-06Pyrrolidinone carboxamide derivatives
#75 | 2013-08-29 ✅ Patent 8,916,601 granted on 2014-12-23Aza-aryl 1H-pyrazol-1-YL benzene sulfonamides
#76 | 2013-07-183-(IMIDAZOLYL)-PYRAZOLO[3,4-B]PYRIDINES
#77 | 2013-07-11 ✅ Patent 8,946,240 granted on 2015-02-034-amino-3-(imidazolyl)-pyrazolo[3,4-D]pyrimidines
#78 | 2013-07-04 ✅ Patent 8,835,419 granted on 2014-09-16Substituted anilines as CCR(4) antagonists
#79 | 2013-06-27 ✅ Patent 8,685,959 granted on 2014-04-01Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists
#80 | 2013-03-07 ✅ Patent 9,133,124 granted on 2015-09-15Crystalline form of the sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide
#81 | 2012-09-27 ✅ Patent 8,835,468 granted on 2014-09-16N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl) arylsulfonamides
#82 | 2012-06-28 ✅ Patent 8,481,579 granted on 2013-07-09Triazolyl phenyl benzenesulfonamides
#83 | 2012-01-12 ✅ Patent 8,481,545 granted on 2013-07-093-(imidazolyl)-pyrazolo[3,4-b] pyridines
#84 | 2011-12-29 ✅ Patent 8,546,408 granted on 2013-10-01Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation
#85 | 2011-11-10C5aR ANTAGONISTS
#86 | 2011-10-20 ✅ Patent 8,642,808 granted on 2014-02-04Bis-aryl sulfonamides
#87 | 2011-07-07COMPOSITIONS AND METHODS FOR DETECTING AND TREATING DISEASES AND CONDITIONS RELATED TO CHEMOKINE RECEPTORS
#88 | 2011-05-19 ✅ Patent 8,519,135 granted on 2013-08-27Heteroaryl sulfonamides and CCR2/CCR9
#89 | 2011-04-28 ✅ Patent 8,383,630 granted on 2013-02-26Azaindazole compounds and methods of use
#90 | 2011-04-07 ✅ Patent 8,293,925 granted on 2012-10-23Pyrrolidinone carboxamide derivatives
#91 | 2011-03-03COMPOSITIONS AND METHODS FOR DETECTING AND TREATING DISEASES AND CONDITIONS RELATED TO CHEMOKINE RECEPTORS
#92 | 2011-01-27 ✅ Patent 8,211,896 granted on 2012-07-03Aryl sulfonamides
#93 | 2011-01-20MODULATORS OF CXCR7
#94 | 2010-12-30 ✅ Patent 8,198,309 granted on 2012-06-12N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl)hetaryl arylsulfonamides
#95 | 2010-12-09C5aR ANTAGONISTS
#96 | 2010-12-09 ✅ Patent 8,853,202 granted on 2014-10-07Modulators of CXCR7
#97 | 2010-11-30 ✅ Patent 7,842,693 granted on 2010-11-30Substituted piperazines
#98 | 2010-11-04REAGENTS THAT BIND CCX-CKR2
#99 | 2010-09-30Methods and Compositions For Modulating Angiogenesis
#100 | 2010-09-23 ✅ Patent 8,324,216 granted on 2012-12-04Substituted piperazines
Also check out CHEMOCENTRYX, INC.'s (Mountain View, United States) applicant profile with 116 patent applications submitted.
12923 ⎘